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Abstract
Intensity-modulated radiotherapy (IMRT) is a radiation technique used in the
treatment of head-and-neck cancer patients. IMRT results in a dose distribu-
tion which conforms to the tumor volume(s), and therefore sparing surrounding
normal tissue. However, the radiation delivery is relatively time consuming.
Volumetric modulated arc therapy (VMAT) on the other hand, has a radiation
delivery time down to one third compared to that of IMRT (depending on num-
ber of arcs, arc lengths etc.). This shortened treatment time will allow more
treatments per day, and a decrease in discomfort which may be experienced
by the patients undergoing radiotherapy. Due to the differences in radiation
delivery time, it is of interest to compare the dose distributions resulting from
IMRT and VMAT radiation treatment plans.
In this study, ten head-and-neck cancer patient cases were used to compare the
modalities step-and-shoot IMRT, single-arc VMAT, dual-arc VMAT (two arcs
of 356◦ each) and short dual-arc VMAT (two arcs of 270◦ each). The Delta4
phantom from ScandiDos was used to measure the resulting dose distributions
from each of the 40 radiation treatment plans (4 modalities, 10 patient cases).
Each measured dose distribution was then compared with its corresponding
calculated phantom dose distribution, which was obtained in Oncentra Mas-
terPlan (treatment planning system) by using artificial CT-images representing
the phantom’s composition and dimensions.
The gamma index was used as the comparison parameter, and the percentage
of gamma index values which were ≤1 defined the agreement between a mea-
sured and calculated dose distribution. The gamma index criteria were set to
allow max dose deviation and max spatial deviation of ±3,0% and ±3,0 mm
respectively, and the deviations were normalized to local dose.
In order to further compare the radiation modalities, different dose param-
eters were retrieved from the calculated patient dose distributions resulting
from each of the four modalities. The parameters which were assessed were
mean dose to parotis, maximum dose to medulla spinalis, homogeneity index
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for certain treatment volumes (PTVs), and Jaccard index (conformity index)
for all treatment volumes combined. The radiation delivery time was also
measured for each treatment modality used in this study.
In the second part of this study, two systematic MLC leaf positioning errors
(MLCpe) were introduced to the treatment plans single-arc VMAT, dual-arc
VMAT (two arcs of 356◦ each) and IMRT of all ten patient cases. The two
error-types consisted of 1) a +1 mm shifting of each MLC leaf (opening of
aperture), and 2) a -1 mm shifting of each MLC leaf (closing of aperture).
The dose distributions resulting from the MLCpe treatment plans, as well as
the error-free plans, were measured using the Delta4 phantom. The effects
of the errors were evaluated by calculating the relative deviation in mean,
minimum and maximum dose within certain chosen volumes.
The obtained percentages of gamma index values ≤1, show that the accordance
between measured and calculated dose distributions was best for the modality
IMRT. However, all four treatment modalities had percentages satisfying the
pass/fail criteria used at the Department of Radiotherapy (St. Olav’s Hospi-
tal). In terms of the dose parameters which were retrieved from the calculated
patient dose distributions, the largest differences between modalities were seen
in radiation delivery time and homogeneity index. The three VMAT modal-
ities had markedly shorter radiation delivery times compared to IMRT. The
homogeneity indexes, which were calculated for two chosen treatment volumes
(PTVs), indicate that the modalities dual-arc and short dual-arc result in best
homogeneity for the two volumes, whereas IMRT results in the poorest.
The relative deviations in various dose parameters, due to systematic MLC
leaf positioning errors (MLCpe), indicate that the VMAT modalities single-
arc and dual-arc are generally more affected by systematic MLCpe compared
to IMRT. However, for all three evaluated modalities, unwanted clinical effects
due to systematic MLCpe may occur for all assessed volumes, due to relatively
large deviation percentages.
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Sammendrag
IMRT (intensity-modulated radiotherapy) er en str˚aleterapiteknikk som brukes
til behandling av øre-nese-hals kreftpasienter. IMRT resulterer i en dose-
fordeling som er konform til tumorvolumene, og sk˚aner derfor omkringliggende
normalvev. Tiden som brukes til a˚ avlevere str˚alingen derimot, er relativ
lang. Til sammenligning har VMAT (volumetric modulated arc therapy) en
str˚aleleveringstid som er ned til en tredjedel av tiden brukt ved IMRT, avhengig
av antall buer (‘arcs’), buelengder osv. Denne reduseringen av behandlingstid
vil føre til at flere behandlinger kan bli gjennomført per dag, og ubehag som
kan oppleves av pasientene som gjennomg˚ar str˚alebehandling vil reduseres.
P˚a grunn av forskjellene i str˚aleleveringstid, er det av interesse a˚ sammenligne
dosefordelingene som resulteres av IMRT- og VMAT str˚alebehandlingsplaner.
I dette studiet ble behandlingsplanene til ti øre-nese-hals kreftpasienter brukt
til a˚ sammenligne str˚aleterapiteknikkene ‘step-and-shoot’ IMRT, ‘single-arc’
VMAT, ’dual-arc’ VMAT (to ’arcs’ p˚a 356◦ hver) og ’short dual-arc’ VMAT
(to ’arcs’ p˚a 270◦ hver). Delta4-fantomet fra ScandiDos ble brukt til a˚ ma˚le
de resulterende dosefordelingene fra hver av de 40 str˚alebehandlingsplanene (4
teknikker, 10 pasienter). Hver ma˚lte dosefordeling ble deretter sammenlignet
med den tilhørende beregnede dosefordelingen, som ble beregnet i Oncentra
MasterPlan (planleggingssystem for str˚alebehandlinger) ved hjelp av kunstige
CT-bilder som representerte fhantomets sammensetning og dimensjoner.
Gamma-indeksen ble brukt som sammenligningsparameter, og andelen gamma-
indeksverdier som var ≤1 definerte overensstemmelsen mellom en m˚alt- og
beregnet dosefordeling. Kriteriene til gamma-indeksen ble satt til a˚ tillate
maks doseavvik og maks romlig avvik p˚a henholdsvis ±3,0% og ±3,0 mm, og
avvikene ble normalisert til lokal dose.
For ytterligere a˚ sammenligne str˚aleterapiteknikkene, ble ulike doseparame-
tre hentet ut fra de beregnede pasientdosefordelingene som resulterte fra hver
av de fire str˚aleteknikkene. Doseparametrene var som følger; gjennomsnittlig
dose til parotis, maksimumsdose til medulla spinalis, homogenitetsindeks for
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enkelte behandlingsvolum (PTV), og Jaccard-indeks (konformitetindeks) for
alle behandlingsvolum kombinert. I tillegg ble str˚aleleveringstiden m˚alt for
hver str˚aleterapiteknikk som ble evaluert i dette studiet.
I andre del av dette studiet ble to systematiske posisjoneringsfeil i MLC-
bladene (MLCpe) introdusert til behandlingsplanene ‘single-arc’ VMAT, ‘dual-
arc’ VMAT (to ’arcs’ p˚a 356 ◦ hver) og ‘step-and-shoot’ IMRT for alle ti
pasienter. De to systematiske feilene besto av 1) en +1 mm forskyvning av
hvert MLC-blad (utvidelse av str˚alefeltet), og 2) en -1 mm forskyvning av
hvert MLC-blad (innsnevring av str˚alefeltet). Dosefordelingene som resulterte
fra behandlingsplanene med MLC-feil, samt dosefordelingene som resulterte
fra behandlingsplanene uten MLC-feil, ble ma˚lt ved hjelp av Delta4-fantomet.
Effektene av MLC-feilene ble evaluert ved a˚ kalkulere det relative avviket i
gjennomsnittsdose, minimumsdose og maksimumsdose for utvalgte volum.
De kalkulerte prosentverdiene som beskriver antallet gammaindeks-verdier ≤1,
viser at samsvaret mellom ma˚lt og beregnet dosefordeling var best for str˚ale-
terapiteknikken IMRT. Det er viktig a˚ p˚apeke derimot, at alle fire teknikker
hadde prosentverdier som tilfredsstiller kriteriene brukt p˚a avdelingen for str˚ale-
terapi ved St. Olavs Hospital. N˚ar det gjelder doseparametrene som ble hentet
ut fra de beregnede dosefordelingene i pasientene , er de største forskjellene
mellom str˚aleteknikkene funnet i str˚aleleveringstid og homogenitetsindeks. De
tre VMAT teknikkene hadde betydelig kortere str˚aleleveringstider sammen-
lignet med IMRT. Homogenitetsindeksen, som ble kalkulert for to utvalgte be-
handlingsvolum (PTV), indikerte at str˚aleterapiteknikkene ’dual-arc’ og ’short
dual-arc’ resulterer i best homogenitet for begge volumene, mens IMRT resul-
terer i d˚arligst homogenitet.
De relative avvikene i ulike doserverdier, som var grunnet systematiske posisjo-
neringsfeil i MLC-bladene, tyder p˚a at VMAT teknikkene ‘single-arc’ og ’dual-
arc’ er generelt mer p˚avirket av systematiske MLC-feil sammenlignet med
IMRT. Det er viktig a˚ p˚apeke derimot, at alle tre str˚aleteknikker kan føre
til uønskede kliniske effekter i de evaluerte volumene, grunnet relativt høye
prosentavvik.
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Introduction
Intensity-modulated radiotherapy (IMRT) is a radiation technique used for
treatment of head-and-neck (H&N) cancer patients. In IMRT, multiple radi-
ation beams of varying intensity are used to deliver a conform dose to the
tumor, limiting the dose to surrounding normal tissue [2]. However, the radia-
tion delivery for H&N cancer patients is relatively time consuming with IMRT,
lasting around 10–15 minutes per treatment. By reducing the radiation de-
livery time, more patients can undergo treatment per day, and the discomfort
related to receiving radiotherapy will be less. It is important though, that
treatment outcome for the patient is not worsened due to shortened radiation
delivery time.
Volumetric modulated arc therapy (VMAT) is a radiation modality proposed
by Yu in 1995, which has been shown to reduce treatment time down to one
third compared to that of IMRT for H&N cancer patients [3, 4, 5]. VMAT
results in an intensity modulated dose distribution, as for IMRT, but instead
of consisting of a discrete number of radiation beams, the radiation is ad-
ministered continuously during treatment. While the gantry is moving in an
arc around the patient at varying speed, the dose rate and multi-leaf collima-
tor are adjusted simultaneously to achieve the desired dose distribution. A
VMAT treatment can consist of several arcs, with each arc having a defined
gantry-angle range.
To ensure that the reduced radiation delivery time of VMAT does not affect the
treatment outcome compared to IMRT, the dose distributions resulting from
these two radiation techniques must be evaluated and compared. When doing
so, two factors are important to assess; 1) dose parameters which are retrieved
from the calculated patient dose distributions, and 2) the accordance between
measured and calculated dose distribution for each radiation treatment plan
to ensure that the dose distribution deposited in the patient is as desired.
In my specialization project [1], dose distributions resulting from the modali-
ties step-and-shoot IMRT and single-arc VMAT were compared. The results
1
indicate that the reproducibility of measured dose distributions is larger for
single-arc VMAT compared to IMRT. Reproducibility is important in radio-
therapy for H&N cancer patients since the radiation treatment is executed in
several fractions over a longer period of time. The results from my project
also indicate that single-arc VMAT leads to poorer accordance between mea-
sured and calculated dose distributions, compared to IMRT. This implies that
single-arc VMAT is less accurate than IMRT. Having the reduced radiation
delivery time of VMAT compared to IMRT in mind, as well as VMAT’s re-
producibility, it is of interest to investigate various VMAT modalities to see
if the accuracy of VMAT, as well as parameters describing dose distribution,
can exceed IMRT.
Both of the radiation techniques IMRT and VMAT consist of MLC-based ra-
diation delivery. Studies have shown that errors in MLC leaf positioning result
in dosimetric changes, and may effect the treatment outcome [6, 7]. It is there-
fore of interest to evaluate dose deviations due to MLC leaf positioning errors,
for dose distributions resulting from IMRT and VMAT radiation treatment
plans.
2
Background theory
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Chapter 1
Radiation equipment and
treatment modalities
1.1 Linear accelerator
In radiotherapy, a linear accelerator (linac) produces the electrons and photons
used for radiation treatment (figure 1.1) [8]. An electron gun sends out pulses
of electrons to a wave-guide, where they are transported and accelerated by
pulses of microwaves. At the end of the wave-guide the electrons are deflected
in a magnetic field, so the radiation beam is pointed towards the patient.
The final output from the treatment head of the linac can either be an electron
beam, or a beam of X-rays (photons). The photons are produced by the
collision of the accelerated electron beam with a heavy metal target [8]. The
housing of the linear accelerator is called the gantry, and it can be rotated
360◦ around the patient (figure 1.1).
The treatment table is positioned in the xy-plane, and can be moved along all
three axes (figure 1.1).
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Figure 1.1: Schematic drawing of a linear accelerator, and the definition of the isocentre.
The figure was taken from a presentation in the course FY8409 at NTNU.
1.1.1 Monitor Units
A monitor unit (MU) defines the relationship between the radiation output of
the linear accelerator, and the dose delivered by the beam [8]. It is common to
calibrate the linac so that a MU corresponds to 1/100 gray (Gy) at a specific
point in a phantom, with a specific field size. At the Department of Radiother-
apy at St. Olav’s Hospital, the linacs are calibrated so that 100 MU corresponds
to 1 Gy at a depth of 10 cm in water, with a field size of 10 cm X 10 cm and
a distance of 90 cm between the linac source and water surface.
1.1.2 Isocentre
The isocentre of a linear accelerator is the intersection point between the beam
central axis and the rotational axis of the gantry (figure 1.1) [8], and is made
visible in the treatment room by the intersection of horizontal side lasers,
vertical side lasers, and a saggital roof-laser. The isocentre is used as a reference
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point when treatment plans for a patient is being made, and a spatial point
on/in the patient’s body is defined which must coincide with the isocentre
during treatment. The lasers in the treatment room defining the isocentre are
therefore used for correct positioning of the patient.
1.1.3 Multi-leaf collimator
A multi-leaf collimator (MLC) is a device placed in the linac treatment head,
and is used in radiotherapy to shape the radiation field that is being delivered
to the patient/phantom (figure 1.1) [8]. There are several variants of the MLC
depending on the vendor and purpose of use, but the principle is the same for
all MLCs. Since Elekta linear accelerators were used for the measurements in
this study, the Elekta multi-leaf collimator will be described.
The Elekta MLC consists of three major components; 40 MLC leaf pairs,
backup jaws and lower jaws (figure 1.2)[9]. These components are made of
metal, and are combined to attenuate the radiation beam where radiation is
not desired, i.e. shape the radiation beam. The leaf pairs are arranged in two
opposing banks, and within each bank the leaves are placed side-by-side along
the x-axis (figure 1.2). The leaves can move in and out of the radiation beam
along the y-axis. Depending on the vendor, certain constraints are given to
the leaves, and for the Elekta MLC one of these is a minimum gap of 5 mm
between opposing leaf pairs [9].
Figure 1.2: Schematic drawing of the Elekta multi-leaf collimator. The image is taken
from [10].
The backup jaws in the Elekta MLC are placed right below the leaf pairs,
and follow the movement of the leaves along the y-axis. The purpose of the
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backup jaws is to ensure minimal inter-leaf radiation leakage, i.e. leakage
between adjacent leaves within a leaf bank. Another component that decreases
unwanted dose deposition is the pair of lower jaws (figure 1.2). These jaws
travel along the x-axis (orthogonal direction to the the MLC leaf direction),
and cover the leaves which are not active in the field shaping. Radiation
passing through the 5 mm gap between opposing inactive leaves will therefore
be attenuated by the lower jaws.
Rotation in the xy-plane of the MLC as a whole is possible, with the beam
central axis as the rotational axis (figure 1.1). This increases the number of
different field shapes which can be formed.
1.2 Radiation treatment modalities
When treating head-and-neck (H&N) cancer patients with radiotherapy, sev-
eral modalities can be used. Amongst them are the static and dynamic tech-
nique of intensity-modulated radiotherapy (IMRT), as well as volumetric mod-
ulated arc therapy (VMAT) [11]. These treatment modalities consist of MLC-
based delivery, and the same radiation delivery equipment can be used for each
modality.
1.2.1 Intensity-modulated radiotherapy
IMRT is a radiation technique in which the intensity of the radiation beam
is modulated [12]. An IMRT treatment for (H&N) cancer patients usually
consists of 5-9 radiation beams from different gantry angles, and each beam
is composed of several segments which can vary in size and shape. For each
radiation beam/gantry angle, the segments are formed using a multi-leaf col-
limator, and the combination of them results in an intensity-modulated dose
delivery (figure 1.3).
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Figure 1.3: An illustration of combining MLC-shaped segments to obtain an intensity-
modulated dose distribution for a certain radiation beam/gantry angle. Lighter areas in
the dose distribution correspond to higher dose depositions. Figure is taken from [13].
The end result of an IMRT treatment, when all segments for every radiation
beam have been delivered, is a three dimensional, non-uniform dose distribu-
tion which conforms to the tumor. This implies high dose to tumor volumes
(volumes receiving treatment), and low dose to surrounding normal tissue.
Step-and-shoot
’Step-and-shoot’ is a static IMRT technique in which each radiation beam
consists of several discrete segments, and the radiation is turned off between
the segments [12]. First, the gantry and MLC leaves assume their starting
positions. The radiation is then turned on, and the amount of monitor units
for that specific segment is delivered by the linac. The radiation is then turned
off, the MLC leaves relocate to create the next segment shape, and a new
output of radiation is given. This process is repeated for every segment within
all beams/gantry angles in the treatment plan.
Sliding windows
’Sliding windows’ is also an IMRT technique with fixed gantry angles, but what
makes it different from ’step-and-shoot’ is that the segments are delivered in
a dynamic matter [12]. During dose delivery for a specific beam/gantry angle,
the radiation is continuously on with constant intensity while the MLC leaves
move across the radiation field (figure 1.4). All leaves move in the same,
single direction, and the velocity of each leaf is modulated for each radiation
beam/gantry angle to obtain the desired dose distribution.
9
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Figure 1.4: An illustration of the IMRT technique ’sliding windows’ for a certain radiation
beam/gantry angle. The arrow indicates movement direction of MLC leaves, and the
radiation is continuously on. a) Position of leaves at time t1; red border indicates beam
shape at t1. b) Position of leaves at time t2 > t1; green border indicates beam shape
at t2.
1.2.2 Volumetric modulated arc therapy
Volumetric modulated arc therapy (VMAT) is a radiation technique in which
the gantry moves continuously around the patient, while the radiation is con-
stantly on. The gantry has varying speed, and the dose rate (MU per time)
also varies [12, 3]. The shape of the treatment field changes dynamically during
gantry rotation due to the varying velocities and positions of the MLC leaves,
which can move back and forth along the y-axis (figure 1.2). The result of a
VMAT treatment is, as for IMRT, an intensity modulated dose distribution
which conforms to the tumor volumes.
A single rotation of up to 360◦ of the gantry is defined as an arc, and the number
of arcs used for treatment is optional. Depending on the aperture models used
for radiation delivery, different restrictions apply to gantry rotation, dose rate,
and speed and position of MLC leaves.
10
Chapter 2
Specifying dose plans for
radiotherapy
Before the radiation treatment can take place, a dose plan for the patient case
has to be made. This process includes the following;
◦ delineating tumor volumes and labelling them with desired dose levels
◦ delineating organs that need to be spared from irradiation
◦ determining radiation beam settings
◦ optimizing the dose plan to achieve best possible dose distribution in the
patient
In the following sections, the steps of this process will be briefly described.
2.1 Delineating tumor volumes and ’organs at
risk’
To be able to create a customized radiation treatment plan, certain volumes
in the treatment area of the patient must be defined. These volumes are
gross tumor volume (GTV), clinical target volume (CTV), planning target
volume (PTV), and organ at risk (OAR), and are described in the following
subsections. For a single patient case, multiple GTVs, CTVs, PTVs and OARs
may exist, and all these volumes are independently delineated in the axial slices
of the patient CT-images taken prior to treatment.
11
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The delineated volumes are geometrical, with fixed positions and shapes rel-
ative to the linac’s isocentre (section 1.1.2). A spatial point in the patient’s
body is defined in the patient CT-images to show where the isocentre shall
coincide during treatment, and is used as the reference point when delineating
the volumes.
2.1.1 GTV and CTV
The gross tumor volume (GTV) is defined by the palpable or visible/demonstrable
extent of malignant growth [14], and is the starting point when delineating vol-
umes for radiotherapy treatment (figure 2.1).
CTV defines the volume that contains subclinical microscopic malignant dis-
ease which can not be seen on the CT-images [14]. The clinical target volumes
are, in most cases, an outer border of the GTV (figure 2.1), but they can also
be separate volumes.
Figure 2.1: Schematic illustration of the volumes and margins used when delineating
tumor volumes. GTV = gross tumor volume, CTV = clinical target volume, PTV =
planning target volume
2.1.2 Margins and PTV
When patients are undergoing radiotherapy, internal movement can not be
avoided. During treatment, this movement may shift the positions of the
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tumor volumes in the patient relative to the positions of the delineated volumes
(which are fixed relative to the isocentre). To take internal movement into
consideration, an internal margin is added to the CTV (figure 2.1) [14].
Radiation treatment for head-and-neck cancer patients is executed in several
fractions over a longer period of time (several weeks). Variability in the pa-
tient’s position from treatment to treatment may therefore occur. Another
variability which may effect the final dose distribution is possible patient move-
ment during irradiation. In order to include these two uncertainties, a set-up
margin is also added to the CTV (figure 2.1) [14].
The combination of internal margin (IM) and set-up margin (SM) is defined
as total margin (TM). Normally, IM and SM can not be linearly added [14],
but if the two margins are regarded as independent of one another, the total
margin can be mathematically described as
TM =
√
IM2 + SM2. (2.1)
The result of adding total margin (TM) to CTV, is the planning target volume
(PTV). There can be several PTVs within each patient case, and each PTV
contour is labelled with the desired dose level needed to fulfil the treatment
purpose. For instance, the notation PTV54 indicates that the PTV in question
is intended to receive 54 gray (Gy).
Since the PTVs take both treatment variabilities and subclinical microscopic
malignant disease into consideration, it is these delineated volumes which are
used when choosing radiation settings for treatment (section 2.2).
2.1.3 Organs at risk
Dose deposition in the patient may not be wanted in all parts of the treatment
area. Certain organs can lose their functions when receiving dose, and this can
cause discomfort, pain, and/or harm to the patient. These so-called organs at
risk (OARs) should be spared from radiation, but sometimes, when they are
adjacent to tumors, they must receive dose deposition as a sacrifice in order
to get full radiation coverage of the tumour volumes.
To minimize damage of the OARs, their volumes are outlined in the CT-
images along with the GTVs, CTVs and PTVs, and are taken into account
when producing the optimal radiation plan (section 2.2). For head-and-neck
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cancer patients, two important OARs are parotis (parotid glands) and medulla
spinalis (spinal cord) [11].
2.2 Radiation beam settings and optimization
When GTVs, CTVs, PTVs and OARs have been delineated in the patient CT-
images, the following settings are decided; which treatment modality shall be
used, number of radiation beams/arcs and their accompanying gantry angles,
radiation output (photons/electrons), and beam energy.
When the radiation beam settings have been chosen, inverse planning is used
to obtain the desired dose distribution, and is executed using a treatment plan-
ning system. Inverse planning is a method where dose requirements and con-
straints are assigned to the delineated PTVs and OARs (with accompanying
weighting factors determining the importance), and an optimization algorithm
is run to create the beam intensity patterns for each beam/arc needed to obtain
the desired dose distribution [15]. The result of optimization is a proposed ra-
diation treatment plan (number and size of segments, number of monitor units
per segment etc.), as well as the calculated patient dose distribution resulting
from the proposed plan. If the dose planner is not satisfied with the calculated
dose distribution, the requirements, constraints and/or weighting factors can
be changed, and the algorithm run again. This process can be repeated until
the dose planner is satisfied with the optimization results.
An important factor in inverse planning optimization is the use of patient CT-
images, which represent the different densities and compositions within the
patient. They are used in order for the optimization algorithm to correctly
calculate the different intensity patterns needed, since the radiation will be
attenuated differently depending on the densities and structures within the
patient.
When the optimization has lead to a proposed radiation treatment plan, the
patient CT-images are used again, this time in a ’forward manner’ to calculate
the patient dose distribution resulting from the proposed radiation treatment
plan.
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Assessing resulting dose
distributions
For a specific radiation treatment plan, the dose distribution which will be
deposited in the patient is calculated in the treatment planning system (TPS)
based on patient CT-images (section 2.2). Using the same radiation treat-
ment plan, it is also possible to calculate the resulting dose distribution for
other patients/objects. It is then necessary, however, to use CT-images of the
patients/object in question since the radiation will be attenuated differently
through various volumes, depending on composition and dimensions.
The dose distribution resulting from a specific radiation treatment plan can not
only be calculated, but also measured by the use of a phantom. In this study,
the phantom used for measuring dose distributions is the Delta4 phantom
from ScandiDos (section 4). It can be of interest to evaluate the degree of
accordance between the measured dose distribution in the phantom, and the
corresponding calculated dose distribution, i.e. the dose distribution which is
calculated in the TPS based on CT-images of the phantom.
In this study, the dose distribution which is calculated in the TPS based on
CT-images of the patient will be referred to as the ’calculated patient dose
distribution’. Likewise, the dose distribution which is calculated in the TPS
based on CT-images of the Delta4 phantom will be referred to as the ’calculated
phantom dose distribution’.
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3.1 Accordance between measured and calcu-
lated dose distributions
When assessing the accordance between a measured dose distribution, and its
corresponding calculated dose distribution, several parameters can be calcu-
lated. Amongst these are ’dose deviation’, ’distance-to-agreement’ and ’gamma
index’. These three parameters will be described in the following subsections,
where the measured dose distribution will be denoted as m, and the corre-
sponding calculated dose distribution (using correct CT-images) will be de-
noted as c.
3.1.1 Dose deviation
One of the parameters which can be used when comparing measured and cal-
culated dose distribution, is the dose deviation δ(rm, rc), where rm is a pixel
in m, and rc is the pixel in c corresponding to the same spatial coordinates as
rm [16]. The dose deviation can be written as
δ(rm, rc) = Dm(rm)−Dc(rc) (3.1)
where Dm(rm) is the dose in pixel rm, and Dc(rc) is the dose in pixel rc. If
δ(rm, rc) is smaller than a predefined dose deviation requirement ∆D, the pixel
in question will be approved. A drawback with the dose deviation parameter,
however, is that it is very sensitive to small spatial displacements in regions
with steep dose gradients, and the dose deviation can be large without actually
having clinical significance. To adjust for this drawback, a parameter called
distance-to-agreement was developed.
3.1.2 Distance-to-agreement
A second parameter that can be used to compare measured and calculated
dose distribution, is the distance-to-agreement (DTA). This parameter is the
shortest distance between a pixel rm, and a pixel in c that is closest to the
spatial coordinates of rm, where the dose values are equal (figure 3.1) [16]. The
pixels in c with dose equal to the dose in rm, are denoted by rc′ , and the DTA
can therefore be written as
DTA = min{ |rc′ − rm| } given that δ(rm, rc′) = 0 (3.2)
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A predefined requirement of the DTA-value is given, and is symbolized by ∆d.
If the the DTA-value of the pixel rm in question is less than the requirement,
the pixel will be approved.
As with the dose-deviation-parameter, there is a drawback with the DTA-
parameter. If the dose in the region surrounding the pixel rc in question
is approximately homogeneous, one may obtain an unreasonably large DTA-
value, even though the dose difference between rc and rm is small.
rm
m
rc
c
r′c
r′c
r′c
r′c
D
T
A
Figure 3.1: Illustration of the distance-to-agreement (DTA). m = measured dose dis-
tribution; c = calculated dose distribution; rm = pixel in m; rc = pixel in c with same
spatial coordinates as rm; rc′ = pixel in c with dose equal to the dose in rm.
3.1.3 Gamma index
A parameter that takes both the dose deviation δ(rm, rc) and the DTA into ac-
count, is the the gamma index γ [16]. It is a dimensionless measure that is used
in radiotherapy to evaluate the deviation between planned (calculated) and
actual (measured) dose distribution for a given treatment plan. The gamma
index can be written as
γ = min{Γ(rm, rc)} . (3.3)
The Γ-function in the above equation is defined as
Γ(rm, rc) =
√
r2(rm, rc)
∆d2
+
δ2(rm, rc)
∆D2
, (3.4)
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where r is the distance-to-agreement parameter (DTA). For each pixel in m,
a Γ-value is calculated for each pixel in c. If at least one of the Γ-values is less
than, or equal to one, i.e. γ ≤1, the rm pixel in question will be approved.
3.2 Dose distribution parameters
Various parameters can be used to assess a certain dose distribution, and
amongst them are the the homogeneity index (HI) and conformity index (CI)/
Jaccard index (JI). These indexes give an indication of how well the optimiza-
tion dose requirements have been fulfilled, and are described in sections 3.2.2
and 3.2.3.
The input values used to calculate homogeneity index for a certain volume can
be read out from a cumulative dose-volume histogram (DVH). The concept
of a cumulative DVH will therefore be briefly described before defining the
indexes.
3.2.1 Cumulative dose-volume histogram
A cumulative DVH is used to obtain dose distribution data within a certain
volume (e.g. a PTV or OAR), and shows the volume percentage receiving a
dose ≥ a given dose, against dose (figure 3.2) [8].
When calculating the homogeneity index for a certain volume (section 3.2.2),
the dose parameters D2%, D50% and D98% are used. These parameters can be
obtained from the cumulative DVH belonging to the volume in question (figure
3.2, and can be described as follows;
– 2% of the volume receives a dose ≥ D2%
– 50% of the volume receives a dose ≥ D50%
– 98% of the volume receives a dose ≥ D98%
3.2.2 Homogeneity index
The homogeneity index (HI) is an indication of how homogeneous the dose
distribution is within a certain volume [14]. The HI is defined as
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Figure 3.2: Illustration of a cumulative dose-volume histogram (DVH) with accompany-
ing dose parameters. Figure is taken from [14].
HI =
D2% −D98%
D50%
. (3.5)
The dose parameters in the HI-equation can, as mentioned, be read out from
the cumulative dose-volume histogram of the volume in question (figure 3.2).
The lower the HI-value (closer to zero), the more homogeneous dose distribu-
tion in the assessed volume.
3.2.3 Conformity and Jaccard index
The conformity index (CI) can be calculated for a certain PTV, and is a mea-
sure of how conform the dose deposition is to the PTV in question [14]. The
CI is defined as
CI =
VTV
VPTV
. (3.6)
VPTV is the volume of the PTV being evaluated for conformity. VTV is the
’treated volume’, which is the volume within the isodose defining adequate
dose level for treatment. This isodose level is typically defined as 90% or 95%
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of the originally desired PTV dose level. The conformity index can only be
used if either VPTV or VTV fully encloses the other. A CI-value close to 1 is an
indication of good conformity.
The Jaccard index (J) is an extension of the conformity index, and is used
when either the ’treated volume’ or the PTV-volume does not fully enclose
the other [14]. The equation is defined as
J =
VPTV ∩ VTV
VPTV ∪ VTV . (3.7)
Good conformity is indicated by a Jaccard value close to 1.
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Delta4 phantom
The Delta4 phantom (figure 4.1) is a device from ScandiDos which is used
for quality assurance in radiotherapy treatment modalities such as IMRT and
VMAT [17]. It allows the user to verify dose delivery in three dimensions, and
can for instance be used to analyse how deviations in radiation delivery effect
the resulting/measured dose distribution.
4.1 Technical specifications
The shape of the phantom is cylindrical with a diameter of 220 mm and a length
of 400 mm [18]. It is filled with polymethylmethacrylate (PMMA), which is a
homogeneous tissue-equivalent material. Markings of several double lines on
the outside of the phantom case are present to assist the user in the isocenter
alignment of the phantom (figure 4.1).
For detection of deposited dose, the Delta4 phantom contains two crossed,
perpendicular planes consisting of detector arrays [18]. The 60 mm×60 mm
central area of each detector plane contains diodes spaced at 5 mm intervals,
while the diodes in the outer areas are spaced at 10 mm intervals. Summing
these two areas up, the total detection area is 200 mm×200 mm per plane.
4.2 Software
The measurement data obtained using the Delta4 phantom, are saved by the
Delta4 software. Here, the comparison parameters ’dose deviation’, ’distance
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Figure 4.1: Delta4 phantom from ScandiDos.
to agreement (DTA)’ and ’gamma index’ (section 3.1) can be calculated for a
certain measured dose distribution, given that a reference dose distribution is
chosen. The reference dose distribution can be the calculated dose distribu-
tion which corresponds to the measured dose distribution in question, and is
imported to the Delta4 software from MasterPlan for comparison. It is also
possible to chose a measured dose distribution (other than the one in question),
by selecting it as the reference dose distribution in the software program.
To compare calculated and measured dose distribution, the dose deposition in
the phantom detectors are compared with the calculated dose values in the
points corresponding to the spatial positions of the detectors.
4.2.1 Pass/fail criteria
When comparing two dose distributions, the user can define pass/fail criteria
which are based on either dose deviation, DTA, or local gamma index (figure
4.2). If the criteria are based on either dose deviation or local gamma, a
dose range must be chosen to determine which detectors are included in the
calculations. The percentages of the dose range are relative to the maximum
measured dose deposition for the treatment in question.
If the deviation is normalized to the local dose, the normalization dose (100%)
is the maximum measured dose in the measuring point in question.
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If the percentage of detectors which satisfy the given criteria are above the
chosen limit, the treatment plan will be approved. Different criteria can be
applied independently to each measured dose distribution.
Figure 4.2: An example of chosen pass/fail criteria.
4.2.2 Daily correction factor
The daily correction factor (DCF) is a factor which can be applied to mea-
surement data to correct for the daily differences in radiation output of the
linac and/or phantom set-up. In the Delta4 software, the user has the option
of either not applying a factor, inserting a factor manually, or selecting a cer-
tain measurement which the software uses to derived the DCF (figure 4.3). In
the latter case, the factor is the ratio between the total measured dose of all
detectors in the central 6 cm x 6 cm areas of the detector planes, and the total
calculated dose in the spatially corresponding areas.
Figure 4.3: Options for the daily correction factor (DCF).
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Chapter 5
Creating dual-arc VMAT plans
5.1 Case selection
Ten typical head-and-neck cancer patient cases were used for the execution of
measurements in this study. These patient cases are the same as those used in
my project work from the fall of 2012 [1], all of which are from the Department
of Radiotherapy at St. Olav’s Hospital (Trondheim, Norway).
The process of plan creation and exportation, which is described in this chap-
ter, had already been carried out for a single-arc VMAT plan, as well as a
step-and-shoot IMRT plan, for each of the ten patient cases. This was done
in relation with my specialization project [1], and the optimization settings
and dose requirements which had been applied to these plans are shown in
appendices A, B, and D, as well as in figure C.1 in appendix C.
In the following section, single-arc VMAT and dual-arc VMAT will be referred
to as single-arc and dual-arc respectively. Also, step-and-shoot IMRT will be
referred to as IMRT.
5.2 Creation of plans
One of the purposes of this study was to compare the dose distributions re-
sulting from the radiotherapy treatment modalities single-arc, dual-arc and
IMRT. Since dual-arc plans did not exist in the patient cases, they had to be
created using the treatment planning system Oncentra MasterPlan.
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5.2.1 Beam set-up
To create a dual-arc plan within a specific patient case, the single-arc plan from
the chosen case was opened in ’Plan Manager’ mode in Oncentra MasterPlan.
Here, the single-arc plan was copied, and the single radiation beam within the
copied plan was duplicated. This resulted in a dual-arc plan which had the
same isocentre, beam properties, PTVs and OARs as the single-arc plan.
It was decided to make two different dual-arc plans for comparison; one plan
with two arcs of 356◦ each, and another plan with two arcs of 270◦ each. The
beam set-up process described above was therefore repeated twice per patient
case, resulting in two dual-arc plans per case. The radiation beams within these
plans would later be given arc properties to obtain the desired arc lengths of
each dual-arc plan (section 5.2.2).
The reason for creating the dual-arc plan with shorter arcs (270◦ each), was
that for typical head-and-neck cancer cases, the volumes receiving treatment
usually lie in the front part of the patients head (i.e. towards the face). The
shorter radiation arcs may therefore reduce the dose deposition to normal tissue
in the rear parts of the head, compared to the dual-arc with with two arcs of
356◦ each. It was therefore of interest to compare the two dual-arc plans in
regards to resulting dose distribution in the patient.
Figure 5.1: Illustration of gantry angle range for the two dual-arc plans. The patient
contour is an axial slice of the patient’s head.
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5.2.2 Optimization
For the dual-arc plans to be optimized using inverse planning (section 2.2),
desired dose requirements, optimization settings and arc properties had to be
set. This was done in ’Plan Optimization’ mode in Oncentra MasterPlan.
Dose requirements
The dose distributions resulting from the dual-arc plans within each patient
case would be compared with not only each other, but with the dose distri-
butions from the single-arc and IMRT plan of the corresponding patient case.
It was therefore important that the dose requirements were the same for all
modalities within a patient case. Since the dual-arc plans had been created
by copying the single-arc plan in each patient case, the dose requirements
were already identical, and did not require changing. The dose requirements
which were used are from the dose planning guidelines at the Department of
Radiotherapy (St. Olav’s Hospital), and are listed in appendix A.
For the PTVs with desired dose levels which were not listed in the guidelines,
the dose requirements were set to be the same as those used in the single-arc
plans (from my specialization project).
Optimization settings and parameters
The optimization settings for the dual-arc plans were set to be the same as
those for the single-arc plans, with the exception of the settings listed under
the ’VMAT beam settings’-tab (figure C.1 in appendix C). The VMAT beam
settings which were chosen for the two dual-arc plans within each patient case
can be seen in figure C.2 (appendix C), and define the arc properties of the
radiation beams.
From here on out, the VMAT modality consisting of two arcs of 356◦ will be
referred to as ’dual-arc’, and the VMAT modality consisting of two arcs of
270◦ each will be referred to as ’short dual-arc’.
Additional VMAT parameters for each dual-arc and short dual-arc plan were
set to be the same as those for the single-arc plans, and are shown in appendix
D. These parameters describe the limitations of the linear accelerators, and are
given as input to the treatment planning system so the limitations are taken
into account when optimizing the treatment plans. The chosen parameters
are the ones used at the Department of Radiotherapy (St. Olav’s Hospital).
29
MATERIALS AND METHODS
During this study, the linear accelerators were upgraded with new software
(section 6.1.1), enabling the linacs to use a larger number of dose rate values.
The mentioned VMAT parameters used for optimization, however, remained
unchanged despite the software upgrade.
Running the algorithm
When the dose requirements and optimization parameters/settings had been
entered, the optimization algorithm was ready to be run. The check-boxes
for ’Optimization’, ’Final DC (dose calculation)’, and ’Warm start using Final
DC’ were turned on, and the rewind-button was clicked to clear any previous
calculations (figure 5.2). Finally, the algorithm was run by clicking on the
play-button.
Figure 5.2: Settings and buttons for running the algorithm.
When the ’Warm start using Final DC’ button is turned on, the optimization
algorithm is automatically run twice (instead of once), and uses the calculated
dose distribution resulting from the first ’run’ as a starting point for the second
’run’.
The result of the optimization is a proposed radiation treatment plan, as well as
its corresponding calculated patient dose distribution. This dose distribution is
calculated using patient CT-images, which indicate the density of the different
tissues that the radiation beam will pass through (section 2.2).
To ensure that the treatment plan was optimal for the given requirements
and settings, the algorithm was run again by clicking on the play-button a
second time. The rewind-button was not clicked before the algorithm was run,
and since the ’warm start’-button was turned on this time as well, the final
calculated dose distribution from the first optimization process was used as a
new starting point. When the algorithm had been run for the second time,
the resulting radiation treatment plan, and its corresponding calculated dose
distribution, were saved.
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The process of optimization which has been described above, was executed for
both the dual-arc and short dual-arc plans within all ten patient cases.
Since this study was about comparing dose distributions resulting from vari-
ous treatment modalities, the dose plans of the different modalities were set
to have as similar optimization settings and requirements as possible. The
optimization dose requirements and/or settings were therefore not modified to
get clinically accepted dose distributions in the patients, as would be done in a
clinical setting. The reason for choosing similar requirements and parameters
was to ensure that any deviations between dose distributions would be due to
the radiation techniques and/or equipment.
5.2.3 Delta4 file in MasterPlan
When the twenty plans had been optimized (dual-arc and short dual-arc for
each of the 10 patient cases), each plan was exported to a Delta4 file which al-
ready existed in Oncentra MasterPlan. In this file, the dimensions and density
of the phantom were represented as artificial CT-images. Here, each treat-
ment plan was given a new case name, as well as new beam numbers, to avoid
problems with later data export. In addition, the isocenter for each plan was
set to (0,0,0) so the position of the phantom during irradiation would give
correspondence between entered and actual isocenter.
Obtaining calculated phantom dose distribution
For a given optimized radiation treatment plan, the resulting measured dose
distribution in the patient will not be the same as in the phantom due to
the differences in composition and dimensions. The calculated patient dose
distribution from each treatment plan, which was calculated using the pa-
tient CT-images, could therefore not be compared with the measured dose
deposition in the phantom. To be able to compare measured and calculated
dose distribution with measurements executed on the phantom, a calculated
phantom dose distribution was necessary for each dual-arc and short dual-arc
treatment plan. This was obtained in the Delta4 file by using the artificial CT-
images of the phantom in combination with the original radiation treatment
plans calculated for the patient cases.
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Exporting plans and calculated phantom dose distributions
The dual-arc and short dual-arc radiation treatment plan for each patient case
was exported to Mosaiq from MasterPlan. Mosaiq is a patient information
management system, which is used to control the radiation treatment. In
addition, the calculated phantom dose distributions, as well as the radiation
treatment plans, were exported to the Delta4 software.
The dual-arc and short dual-arc radiation treatment plans, with their accom-
panying calculated phantom dose distributions, could now be used to com-
pared measured and calculated dose distribution in the Delta4 phantom. As
mentioned in section 5.1, radiation treatment plans for single-arc and IMRT
already existed, as well as their accompanying calculated phantom dose distri-
butions. Therefore, each patient case now consisted of a radiation treatment
plan for each of the modalities single-arc, dual-arc, short dual-arc and IMRT,
which were ready to be used for measurement execution.
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Equipment and execution of
measurements
6.1 Linear accelerators
In this study, two Elekta linear accelerators were used for the measurement
executions. They will be referred to as SB2 and SB4, where SB stands for
’str˚alebehandling’ (English: radiation treatment). For all measurements in
this study, 6 MV photons were used as the radiation source.
The two linacs had the property of delivering seven discrete dose rate values
(MU/min), with the maximum dose rate being 520 MU/min and 390 MU/min
for SB2 and SB4 respectively. The dose rate values which could be used were
given as a geometric series, with the maximum dose rate as the first element
value, and the next element value being 50% of the previous one.
6.1.1 Software upgrade
During this study, both of the linacs were upgraded with a new software, en-
abling the use of dose rate values on a nearly continuous scale. The maximum
dose rates of SB2 and SB4 were still the same, but the linacs could now select
256 different dose rate values from a given nominal range. The software allow-
ing seven discrete dose rate values will be referred to as the old software, and
the software allowing nearly continuous dose rate values will be referred to as
the new software. Due to the software upgrade, some measurements in this
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study were executed using both the old and new software, as described later
in this chapter (section 6.3).
6.2 Setting up the phantom
Before the treatment plans could be executed on the phantom, it was necessary
to correctly position the phantom, and connect its hardware properly (figure
6.1). The assisting lasers in the treatment room were lined up with the double
lines on the outside of the phantom in order to place the isocentre in the center
point of the phantom.
Figure 6.1: Set-up of the Delta4 phantom. Connector box; receives the trigger signals
from the accelerator and forwards it to the detector units. Inclinometer; is attached to
the gantry and measures the gantry angle.
6.3 Executing treatment plans on the Delta4
The four radiation treatment plans within each patient case (single-arc, dual-
arc, short dual-arc and IMRT), were executed on the Delta4 phantom. Mosaiq
was used to control the irradiation, and the measured dose deposition in the
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phantom, resulting from a certain radiation treatment, was recorded and saved
by the Delta4 software.
Each of the 40 radiation treatment plans (10 patient cases, 4 treatment modal-
ities per case) was executed eight times on the Delta4 phantom; twice on each
linac (SB2 and SB4) with the old software, and twice on each linac with the
new software. This totalled up to 320 measurement executions on the Delta4
phantom.
In addition, the radiation delivery time of all 40 treatment plans was mea-
sured once with the old software, and once with the new software. This was
carried out in order to 1) see differences in times between the four modal-
ities, and 2) see if irradiation with nearly continuous dose rate values (new
software) was faster than with seven discrete values (old software). For the
three VMAT modalities, radiation delivery times were measured independently
for each arc. For the two dual-arc modalities, the delivery time of each arc
was added to obtain total delivery time. This implies that the time it took
to change arcs/radiation beams was not measured. For IMRT, the radiation
delivery times were measured independently for each gantry angle/radiation
beam, i.e. the time it took for all segments to be delivered within a certain
gantry angle. The delivery times of all gantry angles were then added to obtain
the total delivery time.
The same linac (SB4) was used for all radiation delivery time measurements
to ensure that differences in delivery time between modalities would not be
due to differences between the linacs.
6.3.1 Measuring reference field and applying DCF
For each day that a measurement took place, a reference field of 10 cm x 10 cm
with a radiation output of 100 MU, was measured in the Delta4 phantom at
a gantry angle of 0◦. The resulting measured dose distribution from a specific
day was used to derive a daily correction factor (DCF), which was applied to
all measurements executed on the corresponding day.
The reference field already existed in both Mosaiq and the Delta4 software due
to previous measurements taken at the department. Therefore, creation of the
reference field and recalculation of dose distribution to the Delta4 phantom
was not necessary.
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Obtaining parameters from dose
distributions
As part of this study, we wished to obtain parameters describing the dose
distributions resulting from the treatment modalities single-arc, dual-arc, short
dual-arc and IMRT. These parameters would then be used to compare the four
modalities with each other.
7.1 Agreement values
One of the parameters which would be used to compare the four radiation treat-
ment modalities, is the percentage of detectors in the phantom with gamma
index values≤1. This percentage describes the accordance between a measured
dose distribution in the phantom, and the corresponding calculated phantom
dose distribution (chapter 3), and will be referred to as the agreement value.
The agreement value for all 40 measurements executed on the phantom could
be obtained from the Delta4 software since the corresponding calculated phan-
tom dose distributions had previously been exported from MasterPlan to the
Delta4 software (section 5.2.3). When obtaining the gamma-index values, two
different sets of criteria were used. The criteria were first set to allow max
dose deviation and max spatial deviation of ±3,0% and ±3,0 mm respectively,
and then set to allow ±2,0% and ±1,0 mm respectively (figure 7.1). For both
criteria sets, the deviation values were normalized to local dose.
The pass/fail criteria of ±3,0% and ±3,0 mm, with the deviation values being
normalized to local dose, are used for head-and-neck cancer patients at the
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Department of Radiotherapy (St. Olav’s Hospital). For a radiation treatment
plan to be approved at the department, at least 90% of the detectors must
have a gamma index of ≤1. The reason why the Department of Radiotherapy
uses these specific pass/fail criteria, is to keep the clinical impact of radiation
delivery errors at an acceptably low level.
The more strict criteria of ±2,0% and ±1,0 mm were used to more easily see
the differences in accordance between the modalities.
Figure 7.1: The two pass/fail criteria used for evaluation of the treatment modalities.
The criteria on the left are the standard criteria used at the Department of Radiotherapy
(St. Olav’s Hospital).
For both criteria settings, the deviation was normalized to the local dose,
and the dose range was set to be 50% - 500%. The dose range determines
the detectors that will be included in the calculations, and the values define
percentage of maximum measured dose. The reason for choosing 50% as the
lowest dose range value is that below this percentage, the dose is well below
the therapeutic dose, and deviations from calculated dose will not be clinically
significant.
7.2 Parameters from calculated patient dose
distributions
In addition to agreement values, we also wished to obtain various dose parame-
ters from the calculated patient dose distributions in order to evaluate how well
the dose requirements for optimization had been fulfilled within each modality
(single-arc, dual-arc, short dual-arc and IMRT). The dose parameters which
would be obtained were chosen based on dose requirements for optimization
(see appendix A), as well as the importance of a homogeneous and conform
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dose deposition to the PTVs, and were as follows; mean dose to parotis, max-
imum dose to medulla spinalis, homogeneity index, and conformity/Jaccard
index.
Due to a mishap when working with the patient cases, dose values and param-
eters could not be retrieved from patient case number 1.
7.2.1 Retrieving dose values
The parotis is a bilateral structure, and is therefore contoured as two OARs
in the CT-images of the patient. In this study, we wished to retrieve the value
of mean dose to parotis as a whole. A union OAR of the two parotis volumes
was therefore created within each patient case (except case nr. 1), using the
’Image Registration’ mode in Oncentra MasterPlan.
For nine of the ten patient cases, mean dose to parotis as a whole, as well
as the maximum dose to medulla spinalis, were retrieved from the calculated
patient dose distributions resulting from all four treatment modalities. The
values were retrieved using ’Plan Evaluation’ mode in MasterPlan.
7.2.2 Calculation of homogeneity indexes
For the calculation of homogeneity indexes (section 3.2.2), I chose to assess
the two PTVs with dose levels that were most frequent among the patient
cases (see appendix E). These two dose levels were 54 Gy and 68 Gy, and
the PTVs with these desired dose levels are referred to as PTV54 and PTV68
respectively.
For the patient cases containing the two chosen PTVs (except case nr. 1),
which would be the cases used when calculating homogeneity indexes (HI),
PTV54 was partially overlapped by PTV68. We wished to retrieve HI for the
volumes which were intended to receive only 54 Gy, and only 68 Gy. A new
volume named PTV54,exclusive was therefore created, which was the volume of
PTV54 which was not overlapped by PTV68. It was not necessary to create a
PTV68,exclusive volume since PTV68 was the volume with highest dose level in
the chosen patient cases. In other words, when calculating the HI for PTV68,
the input parameters D2%, D50% and D98% would not be effected by the overlap
of PTV54.
The parameters D2%, D50% and D98% were retrieved from the calculated pa-
tient dose distributions resulting from all four modalities, for the volumes
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PTV54,exclusive and PTV68 (within the chosen patient cases). The homogene-
ity indexes for each PTV54,exclusive and PTV68all were then calculated.
7.2.3 Calculation of Jaccard indexes
When assessing the conformity of certain volumes, the Jaccard index (section
3.2.3) would be calculated instead of the conformity index, in case either the
VTV or VPTV did not entirely enclose the other.
For the calculation of Jaccard indexes, I wished to assess the conformity of all
PTVs within a patient case as a whole, i.e. the volume of all PTVs combined.
In order to retrieve the volume measure of all PTVs combined, a union PTV
within each patient case had to be created. This union volume created using
’Image Registration’ mode in MasterPlan, and was named PTVtotal.
For the input parameter ’treated volume’ (section 3.2.3), the isodose contour
of 90% was chosen, and the isodose value was defined by the PTV volume
within each patient case with lowest dose level. This dose-level was 54 Gy for
all patient cases, giving the 90% isodose a value of 48,6 Gy.
For all patient cases (except case nr. 1), the volume measures of ’treated vol-
ume’ (VTV ) and PTVtotal (VPTV ) were retrieved from MasterPlan for each of
the four treatment modalities.
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MLC leaf positioning errors
In this study, systematic MLC leaf positioning errors (MLCpe) were introduced
to the single-arc, dual-arc and IMRT radiation plan of all ten patient cases. For
each of these three modalities, the error-free radiation plans (base plans) and
their corresponding MLCpe plans (which had been modified), were executed
on the Delta4 phantom. The resulting measured dose distributions were saved
by the Delta4 software, and used to assess the effects of MLCpe on single-arc,
dual-arc and IMRT radiation plans.
The short dual-arc plans within the patient cases were not used for MLCpe
measurements in order to limit the amount of measurements.
8.1 Modifying treatment plans
The positions of the MLC leaves in each base plan were modified using a pro-
gram written in the programming language Ruby. For each patient case, copies
of the single-arc, dual-arc and IMRT base plans were modified by introducing
two types of systematic MLC leaf positioning errors. The first error-type con-
sisted of a +1 mm shifting of all leaves (in both leaf banks), resulting in an
opening of the aperture (figure 8.1 b). The second error-type consisted of a
-1 mm shifting of all leaves, resulting in a closing of the aperture (figure 8.1 c).
After introducing MLCpe to the single-arc, dual-arc and IMRT plan of all ten
patient cases, each case had a total of 9 treatment plans; 3 base plans (one
for each radiation modality), 3 plans with a +1 mm error, and 3 plans with
a -1 mm error. The treatment plans with MLC leaf positioning errors were
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Figure 8.1: Illustration of MLC positioning-errors; a) base plan without error, b) system-
atic opening of MLC leaves (+1 mm), and c) systematic closing of MLC leaves (-1 mm).
Red lines indicate the contour of PTV. Figure is taken from [7].
exported to both Mosaiq and the Delta4 software, whereas the base plans had
already been exported due to previous measurements in this study.
Since comparison would only be made between measured error-free dose distri-
butions and measured MLCpe dose distributions, it was not necessary to obtain
a calculated dose distribution for the plans used in these measurements.
8.2 Executing measurements
For each of the 90 treatment plans (9 per patient case, 10 cases), Mosaiq was
used to control the irradiation of the Delta4 phantom. All MLCpe measure-
ments were executed using the SB4 linac with the old software (seven discrete
dose rate values), and the dose depositions in the phantom were recorded and
saved by the Delta4 software. 6 MV photons were used as the radiation source.
Dose deviations resulting from MLCpe treatment plans, relative to their cor-
responding error-free treatment plans, would be compared between the treat-
ment modalities single-arc, dual-arc and IMRT within a patient case. All 9
treatment plans within a patient case were therefore measured on the same
day. This was to minimize possible day-to-day variations in phantom set-up
and radiation output, which could affect the resulting dose distributions and
therefore the deviation values.
All ten patient cases were not measured on the same day due to the time
limitations. This was, however, not of importance since the comparison of
resulting dose distributions would only be made within each patient case, not
between different cases.
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As mentioned, all MLCpe measurements (both the base plans and the MLCpe
plans) were executed using the same linac. This was to avoid possible differ-
ences in radiation output of different linacs, which could effect the results.
8.2.1 Measuring reference field and applying DCF
For each day that a measurement took place, a reference field was measured
in order to apply correct daily correction factor (DCF) to the measurements.
This procedure was done as described in section 6.3.1.
8.3 Assessing PTVs and OARs
For each radiation modality within a patient case, the two measured dose
distributions resulting from systematic MLCpe would be compared with the
corresponding measured error-free dose distribution. It was of interest to assess
deviation parameters within the PTV volumes of each patient case, as well as
within the parotis and medulla spinalis, to assess the effects of MLCpe.
In order to retrieve dose parameters within these volumes from the measured
dose distributions, the volume contours needed to be exported from Master-
Plan to the Delta4 software. However, before this could be done, some of the
volume contours had to be modified as described in the following subsection.
8.3.1 Creating union structures
For some patient cases, there existed several PTVs with the same dose level.
In order to obtain a joint volume for these PTVs, the individual volumes
were combined to create a union structure using ’Image Registration’ mode in
Oncentra MasterPlan. This procedure was done for each PTV dose level that
existed within a patient case.
The different PTV dose levels and OARs which existed for each patient case are
listed in appendix E. Due to a mishap during the creation of union structures,
the volumes for the parotis and medulla spinalis in patient case number 1 were
lost.
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8.3.2 Exporting union volumes to Delta4 software
For each patient case, there now existed a union structure for each PTV dose
level, as well as a union structure for the parotis which had been created pre-
viously in this study (section 7.2). These volumes, in addition to the medulla
spinalis volume, were exported to the Delta4 software from MasterPlan. Dose
parameters within these volumes could therefore be retrieved from the mea-
sured dose distributions, and used to assess the effects of MLC leaf positioning
errors.
Retrieving dose parameters
From the 90 dose distributions which were measured and registered by the
Delta4 software, the following dose parameters were retrieved for each PTV,
parotis and medulla spinalis volume;
◦ minimum dose
◦ maximum dose
◦ mean dose
These parameters were used to assess the effects of MLCpe on the different
treatment modalities.
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Chapter 9
Parameters obtained from dose
distributions
In the present work, parameters were obtained which described the dose dis-
tributions resulting from the treatment modalities single-arc, dual-arc, short
dual-arc and IMRT. These parameters are presented in the following sections,
and were used to compare the four modalities.
9.1 Agreement values
To assess the accordance between a measured dose distribution in the phantom,
and the corresponding calculated phantom dose distribution (chapter 3), the
percentage of detectors in the phantom with gamma index values ≤1, was
used. This percentage value will, as previously mentioned, be referred to as
the agreement value, and a value of 100 indicates full agreement.
Each of the 40 radiation treatment plans (10 patient cases, 4 treatment modal-
ities per case) were executed eight times on the Delta4 phantom; twice on each
linac (SB2 and SB4) with the old software (seven discrete dose rate values),
and twice on each linac with the new software (nearly continuous dose rate
values). For each of these measurements, the agreement value was retrieved for
two different criteria; max dose deviation and max spatial deviation of ±3,0%
and ±3,0 mm respectively, and of ±2,0% and ±1,0 mm respectively. For both
criteria sets, the deviation values were normalized to local dose. The retrieved
agreement values are listed in appendix F.
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For each of the four measurement combinations (SB2/SB4 with old/new soft-
ware), the agreement values were averaged over the 20 measurements within
each modality (10 patients, two measurements each). These averaged values
are listed at the bottom tables F.1, F.2, F.3 and F.4 in appendix F.
SB2 linac
Figure 9.1 presents the average agreement values for the measurements exe-
cuted on the SB2 linac with both the old and new software. The graphs show
that, regardless of software, IMRT has the highest agreement values out of the
four modalities (differences are more clear with stricter gamma index criteria of
±2,0% and ±1,0 mm). This implies that IMRT results in a better accordance
between measured and calculated dose distribution compared to the VMAT
modalities. However, all four modalities show agreement values above 90%
for the criteria of ±3,0% and ±3,0 mm (regardless of software), meaning that
all treatments would be approved at the Department of Radiotherapy at St.
Olav’s Hospital.
Figure 9.1: Average agreement values between measured an calculated dose distributions
for SB2 (tables F.1 and F.2 in appendix F
).
The differences in agreement values due to installation of new software are
also illustrated in figure 9.1. The figure shows that, for the SB2 linac, agree-
ment values increase within all treatment modalities with installation of new
software. This indicates that the usage of nearly continuous dose rate values,
instead of seven discrete values, results in a dose distribution which is more
similar to the desired, calculated dose distribution. The increase in agreement
values due to new software is larger for the VMAT modalities than for IMRT.
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SB4 linac
Figure 9.2 presents the average agreement values for the measurements exe-
cuted on the SB4 linac with both the old and new software. As for the SB2
linac, IMRT shows the highest agreement values out of the four treatment
modalities, regardless of software. This indicates that IMRT results in dose
distributions which are more similar to their corresponding calculated dose
distributions, compared to the VMAT modalities. It is important to notice,
however, that all four modalities would be approved with the gamma index
criteria used at St. Olav’s Hospital, regardless of linac software.
Figure 9.2: Average agreement values between measured an calculated dose distributions
for SB4 (tables F.3 and F.4 in appendix F
).
If we look at the differences in agreement values for SB4 due to installation of
new software (figure 9.2), the gamma index criteria of ±3,0% and ±3,0 mm
show little change in values. However, with the stricter gamma index criteria,
small differences due to the new software appear. The modalities single-arc,
dual-arc and short dual-arc have a slight increase in agreement value, whereas
IMRT shows a small decrease. This indicates that VMAT modalities obtain
improved accordance between measured and calculated dose distributions due
to the software upgrade, whereas IMRT is barely affected.
9.2 Radiation delivery time
The total radiation delivery time of the SB4 linac for each treatment modality
was measured for all ten patient cases. Time measurements were taken with
both the old and new software. The delivery times were averaged over all
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ten patient cases, and these calculated values are presented in figure 9.3. The
graphs show that IMRT has the longest radiation delivery time out of the
four modalities, with both the old and new software. The VMAT modalities
show the same trend regardless of software, with single-arc resulting in shortest
delivery time, and dual-arc resulting in longer delivery time than short dual-
arc. The upgrade of software resulted in markedly shorter average radiation
delivery times for all three VMAT modalities
Figure 9.3: Average radiation delivery times for dose delivery executed on the SB4 linac.
Values are listed in appendix J.
9.3 Parameters from calculated patient dose
distributions
In order to evaluate the calculated patient dose distributions resulting from
various radiation modalities, a number of dose parameters were assessed; mean
dose to parotis, maximum dose to medulla spinalis, homogeneity index and
Jaccard index. These values/indexes were retrieved/calculated for each treat-
ment modality for nine of the ten patient cases, and are listed in appendices
G, H and I. As previously mentioned (section 7.2), dose values and parame-
ters could not be retrieved from patient case number 1 due to a mishap when
working with the patient cases.
9.3.1 Mean dose to parotis, max dose to medulla spinalis
Figure 9.4 shows the average values of ’mean dose to parotis’ and ’maximum
dose to medulla spinalis’ for each treatment modality. The mean dose de-
posited in parotis is very similar for each modality, whereas the maximum
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dose to medulla spinalis is slightly larger for single-arc and IMRT compared
to the two dual-arc modalities.
Figure 9.4: Mean dose to parotis, and maximum dose to medulla spinalis, for different
treatment modalities. Values are listed in appendix G.
9.3.2 Homogeneity index for PTV54,exclusive and PTV68
The homogeneity index (section 3.2.2) was calculated for PTV54,exclusive and
PTV68 (section 7.2.2), and the average values for the nine patient cases are
plotted in figure 9.5. A low homogeneity index value (close to zero) indicates
good homogeneity. The graph shows that the modalities dual-arc and short
dual-arc result in better homogeneity for both PTV54,exclusive and PTV68,
compared to single-arc and IMRT. IMRT results in the largest HI-value within
each assessed PTV, and is therefore the modality which results in poorest
homogeneity.
Figure 9.5: Calculated homogeneity index for PTV54,exclusive and PTV68. Values are
listed in appendix H.
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9.3.3 Jaccard index for PTVtotal
The Jaccard index (section 3.2.3) is a measure of the dose conformity to a cer-
tain volume, and a value close to 1 indicates good conformity. In this study,
the Jaccard index was calculated for PTVtotal (all PTV volumes combined re-
gardless of dose level) for nine of the ten patient cases, and for each treatment
modality. The isodose level which was used when retrieving the ’treated vol-
ume’ values for Jaccard index calculations, was set to be 90% of 54 Gy (section
7.2.3).
The average Jaccard index value for each modality is plotted in figure 9.6.
Figure 9.6: Average Jaccard index for PTVtotal. Values are listed in appendix I.
The graph shows that the average Jaccard index is quite similar for all four
treatment modalities, and that the standard deviations of the modalities over-
lap one another. The conformity can therefore not be said to be markedly
different between modalities.
9.3.4 Representative calculated patient dose distribu-
tions
Figure 9.7 shows the 2-dimensional calculated patient dose distribution (2D-
CPDD) for a chosen axial slice in patient case nr. 3, resulting from single-arc,
dual-arc, short dual-arc and IMRT. The volumes PTV54, PTV68 and medulla
spinalis are delineated in the CT-image, and the combination of PTV54 and
PTV68 define PTVtotal for this specific patient.
The reason for presenting these four 2D-CPDD, is that they give a representa-
tive illustration of some of the differences found between single-arc, dual-arc,
short dual-arc and IMRT regarding dose parameters. Figure 9.7 illustrates
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how the three VMAT modalities result in better conformity to PTVtotal com-
pared to IMRT. The figure also shows how dual-arc and short dual-arc result
in best homogeneity within PTV68 compared to the other modalities. This
is seen by dual-arc and short dual-arc having doses between around 61,2 and
68 Gy, whereas single-arc and IMRT have dose values above 68 Gy as well.
Figure 9.7: 2-dimensional calculated patient dose distribution for a chosen axial slice in
patient case nr. 3, resulting from single-arc, dual-arc, short dual-arc and IMRT.
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MLC leaf positioning errors
Systematic MLC leaf positioning errors (figure 8.1) were introduced to the
single-arc, dual-arc and IMRT base plan of all ten patient cases. As mentioned
in chapter 8, the short dual-arc plans were not used for MLC leaf positioning
error measurements in order to limit the amount of measurements.
The introduction of MLC errors led to a total of 90 treatment plans; 30 base
plans (three modalities, 10 patient cases), 30 plans with a +1 mm error, and
30 plans with a -1 mm error (section 8.1). These 90 radiation treatment plans
were executed on the Delta4 phantom, and the resulting dose distributions
were registered by the Delta4 software. From each of these measured dose
distributions, the following values were retrieved for all PTVs, the union paro-
tis volume and the medulla spinalis volume: minimum dose, mean dose and
maximum dose. The values are listed in appendix K.
All of the retrieved dose values show that with an MLC error of +1 mm
(opening of aperture), both the min, mean and max dose of all volumes increase
relative to the base plan values. Likewise, with an MLCpe of -1 mm (closing of
aperture), all dose values decrease relative to the base plan values. By taking
this fact into consideration, and by looking at the dose requirements used for
optimization of the base plans (see appendix A), only certain values were of
importance when assessing the effects of MLCpe;
◦ mean and minimum dose to PTVs
◦ maximum dose to medulla spinalis
◦ mean dose to parotis
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10.1 Deviations due to MLCpe
For both of the MLCpe types (+1 mm and -1 mm), the deviations of min, mean
and max dose, relative to the corresponding error-free values, were calculated
(appendix K). This was done for all volumes within every patient case, and
for each treatment modality.
For the dose parameters of interest within the PTVs, medulla spinalis and
parotis (see list on previous page), the average deviations across all patients
were calculated, and will be presented in the following subsections. The average
values of PTV deviation parameters were calculated using all PTV volumes
combined, regardless of dose level.
10.1.1 Average deviation in mean dose
Figure 10.1 shows the average deviation in mean dose due to the applied MLC
leaf positioning errors. The deviation values were calculated for the PTVs and
parotis, and for the treatment modalities single-arc, dual-arc and IMRT.
Figure 10.1: Average deviation in mean dose within specific volumes, relative to mea-
surements without MLC leaf positioning errors; red indicates MLCpe of +1 mm, and
blue indicates MLCpe of -1 mm. Values are shown in table L.1 in appendix L.
As seen in the figure, both single-arc and dual-arc show larger deviation in
mean dose compared to IMRT for both the parotis and PTVs, regardless of
MLCpe type. The results indicate that deviation in mean dose is affected
to a larger degree with the VMAT modalities, than with IMRT. Also, the
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percentage values show that parotis is generally more affected compared to
PTVs.
With a -1 mm error, the absolute value of deviation for each volume within
each treatment modality, is similar to the corresponding deviations resulting
from a +1 mm error. This strengthens the statement that deviation in mean
dose to PTVs and parotis is more affected by MLCpe when using the VMAT
modalities compared to IMRT. Comparison of deviation values for the two
volumes show that a -1 mm error effects parotis to a larger degree compared
to PTVs, as was the case with a +1 mm error.
10.1.2 Average deviation in minimum dose
Figure 10.2 shows the average deviation in minimum dose due to the applied
MLC leaf positioning errors. The deviation values are averaged over all PTV
volumes, and for the treatment modalities single-arc, dual-arc and IMRT.
Figure 10.2: Average deviation in minimum dose within PTVs, relative to measurements
without MLC positioning errors; red indicates MLCpe of +1 mm, and blue indicates
MLCpe of -1 mm. Values are shown in table L.1 in appendix L.
The figure shows that the two MLCpe (+1 mm and -1 mm) result in similar
absolute deviation values within each modality. The absolute deviation val-
ues are larger for single-arc and dual-arc compared to IMRT. This indicates
that the VMAT modalities are more affected by MLC errors with regards to
minimum dose, compared to IMRT.
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10.1.3 Average deviation in maximum dose
Figure 10.3 shows the average deviation in maximum dose to medulla spinalis,
due to the applied MLC leaf positioning errors. The deviation values are
calculated for the treatment modalities single-arc, dual-arc and IMRT.
Figure 10.3: Average deviation in maximum dose within medulla spinalis, relative to
measurements without MLC positioning errors; red indicates MLCpe of +1 mm, and
blue indicates MLCpe of -1 mm. Values are shown in table L.1 in appendix L.
As for deviation in mean and minimum dose, the deviation in maximum dose
is larger for single-arc and dual-arc, compared to IMRT, regardless of MLCpe
type.
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Chapter 11
Comparing parameters obtained
from dose distributions
One of the purposes of this study was to compare the radiation treatment
modalities single-arc VMAT, dual-arc VMAT, short dual-arc VMAT and step-
and-shoot IMRT. These modalities will be referred to as single-arc, dual-arc,
short dual-arc and IMRT respectively. Agreement values (percentage of detec-
tors in the phantom with gamma index values ≤1), radiation delivery time,
and a number of dose parameters which were retrieved from the calculated
patient dose distributions, were used for the comparison.
During the study, the linear accelerators were upgraded with new software
allowing the use of nearly continuous dose rate values, whereas previously the
linacs were limited to seven discrete dose rate values (section 6.1.1). The effects
of this upgrade will be discussed in combination with some of the comparison
parameters mentioned above.
11.1 Agreement values
The agreement values which were obtained for the different treatment modal-
ities (figures 9.1 and 9.2) show that IMRT gives better accordance between
measured and corresponding calculated dose distributions, compared to the
three VMAT modalities. A possible reason for the poorer values of single-arc,
dual-arc and short dual-arc, may be that the gantry angle spacing was set to 4◦
for optimization of the VMAT radiation treatment plans (appendix C). This
argument will be explained in the following paragraphs.
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A 4◦ gantry angle spacing implies that the optimized VMAT plans have check-
points for deposited dose and MLC leaf positioning for every 4 degrees. In
other words, a certain amount of monitor units (section 1.1.1) must be deliv-
ered between every pair of adjacent checkpoints, and the MLC leaf positioning
is decided for every 4 degrees. As a result of the 4◦ checkpoint spacing for
VMAT plan optimization, the calculated dose distributions (from the treat-
ment planning system) will be approximations.
The linac, which receives the optimized plan with checkpoint requirements,
decides how these requirements can be achieved in the best possible way, given
its limitations of MLC movement, gantry speed and MU delivery (see appendix
D). Since the radiation treatment plan does not described the exact dose
delivery for all parts of the arc(s), the dose distribution which is measured in
the phantom may differ from the corresponding calculated dose distribution.
For IMRT on the other hand, an optimized radiation treatment plan describes
the fixed/static MLC conformation for each segment, as well as the amount of
monitor units which shall be delivered per segment. This implies that the only
parameter which the linac is allowed to decide, is the dose rate values used for
delivery.
The fact that IMRT radiation treatment plans have a more exact description
of dose delivery compared to VMAT plans, can explain why the agreement
values were higher for IMRT compared to the VMAT modalities.
When assessing the differences in agreement values between single-arc, dual-
arc, short dual-arc and IMRT, it is important to notice that, regardless of linac
(SB2/SB4), all four modalities have average agreement values above 90% with
the deviation criteria of±3,0% and±3,0 mm (deviation values were normalized
to local dose). This implies that all four modalities satisfy the pass/fail criteria
which is used at the Department of Radiotherapy at St. Olav’s Hospital (figure
7.1).
Effects of software upgrade
The installation of new software resulted in the linear accelerators being able
to use nearly continuous dose rate values, instead of seven discrete values. For
measurements executed on both SB2 and SB4, the change in software resulted
in a slight increase in average agreement values for all VMAT modalities (fig-
ures 9.1 and 9.2). A possible reason for the poorer values resulting from the
old software, may be that the treatment planning system (TPS) is permitted
to use continuous dose rate values when optimizing treatment plans. The TPS
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might therefore create a radiation treatment plan with the use of dose rate
values which can not be delivered by the linacs with the old software. This
may result in the measured dose distributions differing from the corresponding
calculated dose distributions, and therefore a reduced agreement value.
If we look at the change in average agreement values for IMRT due to installa-
tion of new software, the changes are relatively small, compared to the VMAT
modalities, or barely present. A possible explanation for these minimal/non-
existing changes, may be that the MLC components and gantry are stationary
while the linac is delivering dose for a certain segment. Due to this fact, the
software upgrade will most likely only affect the dose delivery time, and not
the resulting agreement values.
11.2 Radiation delivery time
When assessing the radiation delivery times of single-arc, dual-arc, short dual-
arc and IMRT (figure 9.3), one can see that IMRT has longer average de-
livery time compared to the VMAT modalities (regardless of software). A
likely reason for the longer delivery time of IMRT, is that for each gantry an-
gle/radiation beam, time is spent on changing between segments, i.e. between
each dose delivery (section 1.2.1). For VMAT on the other hand, the radiation
is continuously on while the MLC components and gantry adjust simultane-
ously. This implies that dose is being delivered continuously, and explains the
shorter radiation delivery times compared to IMRT.
Effects of software upgrade
The linac software upgrade resulted in markedly shorter average radiation
delivery times for the VMAT modalities (figure 9.3), which is in agreement
with previous studies concerning this topic [19, 20]. The shortened delivery
time can be explained by the linac’s ability to choose between 256 dose rate
values for dose delivery, in stead of the old software’s restriction of seven values
(section 6.1.1). This increased liberty will allow the linac to more efficiently
deliver the dose deposition which is required between two checkpoints (section
11.1).
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11.3 Parameters from calculated patient dose
distributions
If we look at the average value of ’maximum dose to medulla spinalis’ for
the four treatment modalities (figure 9.4), we can see that dual-arc and short
dual-arc have slightly lower values than the other two modalities. However, the
standard deviations of all four treatment modalities overlap one another, indi-
cating that the ’maximum dose to medulla spinalis’ values are not considerably
different between modalities.
When assessing ’maximum dose to medulla spinalis’, as well as the other dose
parameters presented in this section, it is important to remember that the
treatment plans in this study were not optimized to get clinically accepted
dose distributions in the patients (section 5.2.2). The same dose requirements,
and as similar optimization settings as possible, were used for each plan to be
able to compare the dose distributions resulting from the different modalities.
Because of this fact, the differences in dose parameters between modalities, can
only give us an indication of how well the dose requirements for optimization
have been fulfilled for the different modalities. The dose parameters do not
indicated how the resulting dose deposition in the patient would be in a clinical
setting.
The average values of ’mean dose to parotis’ for the four treatment modalities
(figure 9.4) are very similar for all four modalities, and are all above the maxi-
mum average dose limit of 23 Gy (appendix A). This may either indicate that
the dose requirement for parotis is difficult to fulfil, or that the treatment plans
need other optimization settings and/or dose requirements to achieve a dose
distribution with lower mean dose to parotis. If the IMRT and VMAT treat-
ment plans had been optimized to get clinically accepted dose distributions,
differences between modalities, regarding mean dose to parotis, may have been
present.
The average homogeneity index (HI) values for PTV54,exclusive and PTV68
were calculated for single-arc, dual-arc, short dual-arc and IMRT, and are
shown in figure 9.5. Regardless of PTV, the three VMAT modalities have
lower HI-values compared to IMRT, indicating better homogeneity. A possible
explanation for these differences, has to do with the amount of angles and
segments which are used for dose delivery. The VMAT modalities continu-
ously deliver dose in arcs around the patient (of up to 360◦ depending on arc
properties), while the MLC components are changing simultaneously. IMRT
on the other hand, is restricted to a certain amount of gantry angles (usually
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between 5 and 9 for head-and-neck cancer patient cases). The amount of dose
delivery possibilities is therefore larger for the VMAT modalities compared to
IMRT, and may describe the increased homogeneity.
11.4 Summary of modality comparison
When evaluating all the parameters which were retrieved/calculated for single-
arc, dual-arc, short dual-arc and IMRT, the largest differences between modal-
ities can be seen in radiation delivery time and homogeneity index. The three
VMAT modalities had markedly shorter radiation delivery times compared to
IMRT, and single-arc had the shortest delivery time of all modalities. The
homogeneity indexes, which were calculated for PTV54,exclusive and PTV68,
indicate that the modalities dual-arc and short dual-arc result in best homo-
geneity for the two volumes, whereas IMRT results in the poorest.
The agreement values which were retrieved with the criteria of ±3,0% and
±3,0 mm (deviation values were normalized to local dose), showed that IMRT
had slightly larger values than the VMAT modalities, and that single-arc had
the lowest values. However, as previously emphasized, all modalities had values
above 90%, which satisfy the pass/fail criteria used at St. Olav’s Hospital
(section 7.1).
It should also be pointed out that with the installation of new software, which
is now in use at the Department of Radiotherapy (St. Olav’s Hospital), the
agreement values for all four modalities were above 96%. This indicates good
accordance between measured and calculated dose distributions for both single-
arc, dual-arc, short dual-arc and IMRT. Also, the software upgrade resulted
in markedly shorter radiation delivery times for the three VMAT modalities.
When evaluating the agreement values in combination with the parameters
obtained from calculated patient dose distributions, it may seem that dual-arc
and short dual-arc are the best options when choosing radiation treatment
modality. They both have high agreement values, markedly shorter radiation
delivery times compared to IMRT, and good homogeneity to PTV54,exclusive
and PTV68. By also assessing the radiation delivery times of the two dual-arc
modalities (figure 9.3), short dual-arc then seems like the best overall modality
option. It should also be mentioned that the use of short dual-arc, compared
to dual-arc, most likely reduces the dose deposition to normal tissue in the
rear parts of the head (section 5.2.1), which is a positive effect.
Finally, it must be emphasized again that the treatment plans in this study
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were not optimized to get clinically accepted dose distributions. Therefore,
the dose parameters retrieved from the calculated dose distributions may not
be representative when comparing radiation modalities. The dose parameters
can, however, give an indication of the differences in optimization quality, i.e.
how well the different modalities fulfil the optimization dose requirements.
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Chapter 12
MLC leaf positioning errors
Systematic MLC leaf positioning errors of +1 mm (opening of aperture) and
-1 mm (closing of aperture) were introduced to the base plans of single-arc,
dual-arc and IMRT for all ten head-and-neck cancer patient cases. The short
dual-arc plans were not used for MLC leaf positioning error measurements in
order to limit the amount of measurements. To assess the effects of the two
systematic MLC errors on the resulting measured dose distributions, deviation
values were calculated within PTV and OAR volumes, relative to the measured
dose distributions from the base plans.
Deviation values were calculated were for the following dose parameters;
◦ mean and minimum dose to PTVs (planning target volumes)
◦ maximum dose to medulla spinalis
◦ mean dose to parotis
12.1 Average deviation parameters
Deviation values regarding each of the dose parameters listed above were calcu-
lated for, and averaged over, all ten patient cases. The average deviation values
are presented in figures 10.1, 10.2 and 10.3, and show that all three modalities
are affected by the two systematic MLC leaf positioning errors (MLCpe). For
all assessed dose parameters, single-arc and dual-arc are affected to a larger
degree compared to IMRT.
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For the treatment of head-and-neck cancer patients, several dose requirements
are assigned to the PTVs and OARs when optimizing radiation treatment plans
(section 2.2). For each PTV within a patient case, two of the requirements
are a uniform dose distribution at a specific dose level, and a lower limit of
minimum dose (see appendix A). These requirements are chosen to ensure that
the treatment purpose is fulfilled, and deviations from the desired uniform dose
level are not desired. This is due to the fact that a resulting dose level below
the desired uniform level may result in survival of cancer cells, while a resulting
dose level above the desired uniform level will increase the dose deposited in
normal tissue, and therefore increase the risk of unwanted side effects.
The average deviation values obtained for ’mean dose to PTVs’ and ’minimum
dose to PTVs’ due to the systematic MLCpe, are presented in figures 10.1 and
10.2. By assessing the two graphs combined, the deviation values indicate
that systematic MLC errors of ±1 mm result in a shift of dose level. As
mentioned above, a shift from the desired dose level is not wanted, and the
MLC errors assessed in this study may therefore have a negative effect on
treatment outcome.
It is also important to assess the effects of MLCpe in regards to parotis and
medulla spinalis. These two organs at risk (OARs) each have a single dose
requirement, which is ’maximum mean dose’ for parotis, and ’maximum dose’
for medulla spinalis (appendix A). In this study, average deviation values
were calculated for the dose parameters ’mean dose to parotis’ and ’maximum
dose to medulla spinalis’, and are presented in figures 10.1 and 10.3. The
graphs show that systematic MLCpe of ±1 mm will result in deviation of the
two assessed dose parameters, and strengthens the assumption that systematic
MLCpe result in a shift of dose level. For parotis and medulla spinalis, it is
of importance that the dose requirements are fulfilled in order to avoid loss of
organ function, which can cause discomfort, pain, and/or harm to the patient.
A systematic MLCpe error of +1 mm will increase the dose level, and is an
unwanted effect regarding parotis and medulla spinalis. A systematic MLCpe
error of -1 mm on the other hand, will not have large effect on the outcome
of parotis and medulla spinals since their only dose requirement is regarding a
maximum level.
12.1.1 Differences in deviation between modalities
For each of the dose parameters discussed in this chapter, the VMAT modal-
ities single-arc and dual-arc have larger deviation values compared to IMRT.
This indicates that VMAT modalities are more affected by systematic MLC
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leaf positioning errors of ±1 mm, than IMRT. A possible reason for this may be
that a VMAT treatment consists mainly of long and narrow segments, whereas
IMRT usually has several segments which are wider. The width of the seg-
ments are defined by the gap between opposing MLC leaves, and an MLCpe
of ±1 mm could therefore give larger deviation percentages for the narrow
segments of VMAT, compared to the wide segments of IMRT.
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Chapter 13
Suggestions for further work
Comparing treatment modalities
The treatment plans in this study were not optimized to get clinically ac-
cepted dose distributions. Therefore, the dose parameters which were re-
trieved/calculated, may not correctly represent the differences between modal-
ities. The dose parameters which were studied in the present work, should
therefore be calculated for patient dose distributions which have been opti-
mized with the intention of achieving best possible dose distribution.
MLC leaf positioning errors
To better assess the clinical effects of systematic MLC leaf positioning errors
(MLCpe), the relative deviations due to the errors should be evaluated in
combination with dose values retrieved from the calculated patient dose dis-
tributions. Doing so, one can evaluate if MLCpe will have a significant effect
on the treatment outcome. In this study, the treatment plans were not opti-
mized to get clinically accepted dose distributions. The dose values from the
calculated patient dose distributions were therefore not used to assess clini-
cal effects from MLCpe, since the dose values did not represent a clinically
optimized dose distribution.
The effect of MLCpe on dose homogeneity within each PTV volume (PTV54,
PTV68 etc.) should be investigated by for instance using the homogeneity
index (section 3.2.2). As previously mentioned, a uniform dose distribution
to PTV at a certain desired dose level is important to achieve the purpose of
treatment. It is therefore not sufficient to evaluate the deviations in mean and
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minimum dose to the PTV volumes, as these values only indicate the shift of
dose level due to MLC errors.
Another important factor to assess, is the effect of MLCpe on resulting PTV
conformity. In order to spare the function of OARs (organs at risk), and
prevent normal tissue from being damaged, it is important to obtain a dose
distribution which conforms well to the PTVs. An MLC error of +1 mm
(opening of aperture) may lead to unwanted dose deposition in normal tissue
and/or OARs surrounding the PTVs. An MLC error of -1 mm (closing of
aperture) on the other hand, may result in PTVs not receiving enough dose
to achieve the treatment purpose. These two examples show the importance
of assessing change in dose conformity due to MLC leaf positioning errors, in
order to avoid unwanted clinical effects.
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Concluding remarks
In this study, ten head-and-neck cancer patient cases were used to compare
the dose distributions resulting from the radiation modalities single-arc VMAT,
dual-arc VMAT, short dual-arc VMAT and step-and-shoot IMRT. Values de-
scribing accordance between measured and calculated dose distributions were
obtained for each radiation treatment modality using the Delta4 phantom, and
various dose parameters were obtained from each calculated patient dose dis-
tribution. In the second part of this study, deviations in dose parameters due
to systematic MLC leaf positioning errors were evaluated for the modalities
single-arc, dual-arc and IMRT.
Comparing radiation modalities
The average agreement values (percentage of phantom detectors with a gamma
index ≤1) which were retrieved from the measurements in this study, show
that the best accordance between measured and calculated dose distributions
was obtained by the radiation modality IMRT. Single-arc was the modality
showing poorest agreement values. However, all four modalities assessed, had
agreement values satisfying the gamma index pass/fail criteria used at the
Department of Radiotherapy (St. Olav’s Hospital).
When evaluating the dose parameters which were obtained for single-arc,
dual-arc, short dual-arc and IMRT, the largest differences between modalities
could be seen in radiation delivery time and homogeneity index. The three
VMAT modalities had markedly shorter radiation delivery times compared to
IMRT. The homogeneity indexes, which were calculated for PTV54,exclusive
and PTV68, indicate that the modalities dual-arc and short dual-arc result in
best homogeneity for the two volumes, whereas IMRT results in the poorest.
The installation of new linac software, allowing the use of nearly continuous
dose rate values in stead of seven discrete dose rate values, resulted in increased
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agreement values, as well as shortened radiation delivery time, for the three
VMAT modalities.
Effects of MLC leaf positioning errors
Relative deviations in various dose parameters, due to systematic MLC leaf
positioning errors (MLCpe) of ±1 mm, were calculated for specific PTVs and
OARs. The results indicate that the VMAT modalities single-arc and dual-
arc are generally more affected by systematic MLCpe compared to IMRT.
However, for all three evaluated modalities, unwanted clinical effects due to
systematic MLCpe may occur for all assessed volumes, due to relatively large
deviation percentages.
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Appendix A
Dose plan specification
Table A.1: Dose requirements for optimization of radiation treatment plans. Require-
ments are from the dose planning guidelines at the Department of Radiotherapy (St.
Olav’s Hospital).
Delineated
volume Requirement Dose level [Gy]
Volume
percentage Weight
PTV - 54 Gy Min dose 51.5 1000
PTV excluded - 54 Gy Max dose volume 56 10% 300
Uniform dose 54 300
PTV - 60 Gy Min dose 57 1000
PTV excluded - 60 Gy Max dose volume 62 10% 300
Uniform dose 60 300
PTV - 68 Gy Min dose 64.5 1000
Uniform dose 68 300
Medulla spinalis Max dose 52 30000
Parotis Max mean dose 23 300
Outer contour Max dose Max PTV + 4 Gy 3000
Surrounding dose falloff 51 to 25 Gy in 2 cm 300
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Appendix B
IMRT optimization settings
Figure B.1: Optimization settings for IMRT
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Appendix C
VMAT optimization settings
Figure C.1: Optimization settings for single-arc VMAT.
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Figure C.2: VMAT beam settings for optimization of VMAT dual-arc (top) and VMAT
short dual-arc (bottom).
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Appendix D
VMAT parameters describing
linac limitations
Figure D.1: VMAT parameters describing linac limitations, which are given as input to
the treatment planning system when optimizing single-arc and dual-arc VMAT treatment
plans.
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Appendix E
Existing patient volumes
Table E.1: Existing PTVs and OARs for each patient case. The PTVs are notated as
PTVD, where D represents the desired/intended dose level given in gray (Gy). Existing
volumes are indicated with ’x’. Due to a mishap, OARs for patient case nr. 1 are missing.
Patient case PTV54 PTV60 PTV66 PTV68 PTV70 parotis
medulla
spinalis
01 x x
02 x x x x
03 x x x x
04 x x x x x
05 x x x x
06 x x x x x
07 x x x x x
08 x x x x x
09 x x x x
10 x x x x x
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Appendix F
Agreement values
Table F.1: Agreement values [%] for the measurements executed on the SB2 linac with
the old linac software (discrete dose rate values). All ten patient cases were measured
twice.
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Table F.2: Agreement values [%] for the measurements executed on the SB2 linac with
the new linac software (nearly continuous dose rate values). All ten patient cases were
measured twice.
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Table F.3: Agreement values [%] for the measurements executed on the SB4 linac with
the old linac software (discrete dose rate values). All ten patient cases were measured
twice.
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Table F.4: Agreement values [%] for the measurements executed on the SB4 linac with
the new linac software (nearly continuous dose rate values). All ten patient cases were
measured twice.
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Appendix G
Dose values from calculated
patient dose distributions
Table G.1: Dose values retrieved from calculated patient dose distributions in Oncentra
MasterPlan; maximum dose to medulla spinalis, and mean dose to parotis. Values are
given in gray (Gy). Due to a mishap when working with the patient cases, dose values
were not able to be retrieved from patient 01.
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Appendix H
Homogeneity indexes
Table H.1: Homogeneity indexes (HI) for PTV54,exclusive and PTV68 with the treat-
ment modalities single-arc, dual-arc, short dual-arc and IMRT. The D98%, D50% and
D2% values are given in gray (Gy).
92
93
Appendix I
Jaccard indexes
Table I.1: Jaccard indexes (J) for PTVtotal (all PTVs combined) for the treatment
modalities single-arc, dual-arc, short dual-arc and IMRT. VTV = treated volume, VPTV
= total PTV volume (regardless of dose-level). Volumes are given in cubic centimetre.
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Appendix J
Radiation delivery times
Table J.1: The total radiation delivery time [sec] for all ten patients with the modalities
single-arc, dual-arc, short dual-arc and IMRT. Time measurements were taken when
executing measurements on SB4, with both the old and new linac software.
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Appendix K
Data from MLCpe
measurements
Table K.1: Data from MLC leaf positioning error measurements for patient case 1.
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Table K.2: Data from MLC leaf positioning error measurements for patient case 2.
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Table K.3: Data from MLC leaf positioning error measurements for patient case 3.
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Table K.4: Data from MLC leaf positioning error measurements for patient case 4.
100
Table K.5: Data from MLC leaf positioning error measurements for patient case 5.
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Table K.6: Data from MLC leaf positioning error measurements for patient case 6.
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Table K.7: Data from MLC leaf positioning error measurements for patient case 7.
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Table K.8: Data from MLC leaf positioning error measurements for patient case 8.
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Table K.9: Data from MLC leaf positioning error measurements for patient case 9.
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Table K.10: Data from MLC leaf positioning error measurements for patient case 10.
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Appendix L
Average dose deviation values
due to MLCpe
Table L.1: Average deviation between measured dose values for certain volumes due to
MLCpe, relative to error-free values. Red values indicate MLCpe of +1 mm, blue values
indicate MLCpe of -1 mm.
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